sábado, 14 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 11, 2026

Bird Reports 2025 Fourth Quarter Results; $11 Billion Combined Backlog and Pending Backlog

View original at globenewswire.com
Bird Reports 2025 Fourth Quarter Results; $11 Billion Combined Backlog and Pending Backlog MISSISSAUGA, Ontario, March 11, 2026 (GLOBE NEWSWIRE) -- “In 2025, Bird successfully navigated near‑term revenue timing shifts while continuing to progress margins and strengthen the business…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Bird successfully navigated near-term revenue timing shifts while continuing to progress margins and strengthen the business in 2025

    60% confidence
  • Bird's risk-balanced combined backlog reflects higher margins than a year ago, giving confidence in achieving growth and further profitability enhancement in 2026 and 2027

    60% confidence
  • Revenue for Q4 2025 was lower than 2024 driven by ongoing impact of previously disclosed delays in start of certain contracted projects

    60% confidence
  • The sole project for the customer with impaired receivables is substantially complete and no further costs are expected to be incurred

    60% confidence
  • Strong demand across key strategic sectors drove record combined backlog with accretive embedded margins, providing historic levels of forward visibility into revenue and earnings growth

    60% confidence
  • Bird remains strongly positioned for Canada's long-duration nation-building investment cycle, including large-scale capital investment energy projects such as LNG and nuclear, as well as infrastructure renewal across defence, healthcare, transportation and trade

    60% confidence
  • With record liquidity and a strong balance sheet, Bird enters 2026 with flexibility, visibility, and momentum

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Bird Reports 2025 Fourth Quarter Results; $11 Billion Combined Backlog and Pending Backlog — Source | Via News | pt.VIA.NEWS